Comerica Bank
AXSM icon

Comerica Bank’s Axsome Therapeutics AXSM Stock Holding History

Comerica Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.32M Sell
12,683
-75
-0.6% -$10.5K 0.01% 1044
2025
Q3 		$1.55M Buy
12,758
+9,362
+276% +$1.05M 0.01% 1288
2025
Q2 		$354K Sell
3,396
-2,792
-45% -$296K ﹤0.01% 2047
2025
Q1 		$722K Sell
6,188
-1,186
-16% -$135K ﹤0.01% 1668
2024
Q4 		$624K Sell
7,374
-3,570
-33% -$328K ﹤0.01% 1778
2024
Q3 		$984K Buy
10,944
+2,965
+37% +$259K ﹤0.01% 1550
2024
Q2 		$642K Sell
7,979
-1,088
-12% -$80.6K ﹤0.01% 1720
2024
Q1 		$723K Buy
9,067
+8,951
+7,716% +$751K ﹤0.01% 1705
2023
Q4 		$9.22K Buy
116
+64
+123% +$4.28K ﹤0.01% 3174
2023
Q3 		$3.62K Buy
+52
New +$3.89K ﹤0.01% 3449

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Comerica Bank's AXSM Position: Q4 2025 in Review

Comerica Bank reduced its Axsome Therapeutics (AXSM) stake by 0.59% in Q4 2025, selling an estimated $10.5K and leaving 12,683 shares worth $2.32M. The position accounts for 0.01% of the portfolio, ranked #1044.

Comerica Bank first reported a position in AXSM in Q3 2023 and has held it in 10 quarters since. 398 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

  • Comerica Bank held 12,683 shares of Axsome Therapeutics worth $2.32M as of Q4 2025.
  • Comerica Bank sold 75 Axsome Therapeutics shares in Q4 2025, an estimated $10.5K.
  • Axsome Therapeutics made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1044 holding.
  • Comerica Bank first reported a position in Axsome Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 398 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.